Published in Stroke on March 01, 1997
Coronary artery calcium, brain function and structure: the AGES-Reykjavik Study. Stroke (2010) 1.45
Atherosclerosis in Takayasu arteritis. Ann Rheum Dis (2006) 1.11
Comparative reproducibility of the noninvasive ultrasound methods for the assessment of vascular function. Heart Vessels (2012) 1.09
Long-term exposure to black carbon and carotid intima-media thickness: the normative aging study. Environ Health Perspect (2013) 1.08
Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol (2008) 0.99
A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases. Clin Rheumatol (2009) 0.98
A practical protocol to measure common carotid artery intima-media thickness. Clinics (Sao Paulo) (2008) 0.91
Carotid intima-medial thickness measured on multiple ultrasound frames: evaluation of a DICOM-based software system. Cardiovasc Ultrasound (2007) 0.88
Relationship between carotid intima-media thickness and coronary angiographic findings: a prospective study. Cardiovasc Ultrasound (2009) 0.86
Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice. Vasc Health Risk Manag (2009) 0.86
Subclinical vascular endothelial dysfunctions and myocardial changes with type 1 diabetes mellitus in children and adolescents. Pediatr Cardiol (2014) 0.84
Assessment of intima-media thickness of carotid arteries: evaluation of an automated computer software. Neuroradiology (2008) 0.84
Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease. Arthritis Res Ther (2010) 0.83
The carotid intima media thickness: a predictor of the clincal coronary events. J Clin Diagn Res (2013) 0.81
Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients. Clin Rheumatol (2014) 0.81
Imaging biomarkers of cardiovascular disease. J Magn Reson Imaging (2010) 0.81
Effects of age and smoking on endothelial function assessed by quantitative cardiovascular magnetic resonance in the peripheral and central vasculature. J Cardiovasc Magn Reson (2015) 0.80
Computer-based quantification of the mean Achilles tendon thickness in ultrasound images: effect of tendinosis. Br J Sports Med (2007) 0.80
Noninvasive effects measurements for air pollution human studies: methods, analysis, and implications. J Expo Sci Environ Epidemiol (2015) 0.79
Influence of hypertension and smoking as the single vascular risk factors on the intima-media thickness. Eur J Epidemiol (2001) 0.79
Real-time co-registration using novel ultrasound technology: ex vivo validation and in vivo applications. J Am Soc Echocardiogr (2011) 0.79
Model-based analysis of flow-mediated dilation and intima-media thickness. Int J Biomed Imaging (2009) 0.78
The relationship between heart-carotid pulse transit time and carotid intima-media thickness in hypertensive patients. J Hum Hypertens (2015) 0.78
Carotid intima-media thickness in young survivors of acute myocardial infarction. Exp Clin Cardiol (2012) 0.77
A methodological approach to non-invasive assessments of vascular function and morphology. J Vis Exp (2015) 0.77
Sequentially based analysis versus image based analysis of Intima Media Thickness in common carotid arteries studies - do major IMT studies underestimate the true relations for cardio- and cerebrovascular risk? Cardiovasc Ultrasound (2008) 0.77
The effect of radioiodine on the intima media thickness of the carotid artery. Mol Imaging Radionucl Ther (2013) 0.77
Chronic stress and the development of early atherosclerosis: moderating effect of endothelial dysfunction and impaired arterial elasticity. Int J Environ Res Public Health (2009) 0.76
Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials. Chin Med J (Engl) (2016) 0.76
Progression of carotid atherosclerosis in patients with systemic lupus erythematosus. Clin Rheumatol (2013) 0.76
Comparison of intima-media thickness and ophthalmic artery resistance index for assessing subclinical atherosclerosis in HIV-1-infected patients. Cardiovasc Ultrasound (2011) 0.75
Arterial adaptations to training among first time marathoners. Cardiovasc Ultrasound (2016) 0.75
Delivery of bevacizumab to atheromatous porcine carotid tissue using echogenic liposomes. Drug Deliv (2016) 0.75
Sex differences in the combined effect of chronic stress with impaired vascular endothelium functioning and the development of early atherosclerosis: the Cardiovascular Risk in Young Finns study. BMC Cardiovasc Disord (2010) 0.75
Insulin resistance and vessel endothelial function. J R Soc Med (2002) 0.75
Different locations but common associations in subcortical hypodensities of presumed vascular origin: cross-sectional study on clinical and neurosonologic correlates. BMC Neurol (2014) 0.75
Is Carotid Artery Ultrasound Still Useful Method for Evaluation of Atherosclerosis? Korean Circ J (2016) 0.75
Multiparametric assessment of vascular function and atherosclerosis in patients with autoimmune gastritis: a comparative study. Dig Dis Sci (2011) 0.75
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2001) 5.18
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13
Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12
Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 3.67
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry (2007) 3.17
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke (1999) 2.49
Hyperhomocysteinaemia as a cardiovascular risk factor: an update. Neth J Med (2000) 2.47
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology (1998) 2.39
Association of intraoperative transcranial doppler monitoring variables with stroke from carotid endarterectomy. Stroke (2000) 2.33
Circle of Willis: morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology (1998) 2.30
Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet (2001) 2.29
Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation (1995) 2.13
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
Ticlopidine, trials, and torture. Stroke (1994) 2.04
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? J Neurol Neurosurg Psychiatry (1999) 2.03
[Ancillary diagnostic imaging is useful if there is atypical evidence of appendicitis]. Ned Tijdschr Geneeskd (2007) 1.97
Age at menopause as a risk factor for cardiovascular mortality. Lancet (1996) 1.94
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Ann Intern Med (1995) 1.93
Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain (2005) 1.85
Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke (1998) 1.82
Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80
Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 1.73
Perimesencephalic hemorrhage. Exclusion of vertebrobasilar aneurysms with CT angiography. Stroke (1999) 1.69
Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation (1999) 1.69
Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Lancet (1992) 1.68
First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophr Res (2010) 1.68
The Atlanta Classification of acute pancreatitis revisited. Br J Surg (2008) 1.67
Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology (2007) 1.64
Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ (1995) 1.62
Outcome in familial subarachnoid hemorrhage. Stroke (1995) 1.59
Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia (2007) 1.59
Quality of life after severe bacterial peritonitis and infected necrotizing pancreatitis treated with open management of the abdomen and planned re-operations. Crit Care Med (2001) 1.56
The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost (2003) 1.55
Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study. Circulation (1996) 1.54
Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation (1999) 1.54
Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology (2007) 1.54
Applicability and relevance of models that predict short term outcome after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry (2005) 1.53
Quality of life after infrainguinal bypass grafting surgery. Dutch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group. J Vasc Surg (1999) 1.49
Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology (1996) 1.48
CT prediction of irresectability in esophageal carcinoma: value of additional patient positions and relation to patient outcome. Abdom Imaging (1997) 1.46
Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol (2001) 1.46
Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand (2000) 1.45
Predicting outcome after acute basilar artery occlusion based on admission characteristics. Neurology (2012) 1.45
Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation (2000) 1.45
Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey. Neth J Med (2006) 1.45
Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1992) 1.44
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. BMJ (2011) 1.44
[Tumor growth during the waiting period for radiotherapy in patients with oropharyngeal carcinoma]. Ned Tijdschr Geneeskd (2003) 1.42
[Timing and choice of intervention in necrotising pancreatitis]. Ned Tijdschr Geneeskd (2005) 1.42
Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A. J Infect Dis (1993) 1.42
Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry (2005) 1.40
[20,000 kg aspirin and 45 pages British Medical Journal]. Ned Tijdschr Geneeskd (1994) 1.40
[Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients]. Ned Tijdschr Geneeskd (2004) 1.40
Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache. J Neurol Neurosurg Psychiatry (1998) 1.39
[Chronicle of a defective heart valve prosthesis]. Ned Tijdschr Geneeskd (1998) 1.39
[Surgery for a recently symptomatic severe carotid stenosis, indicated or not? Clinical application of 'evidence-based' medicine]. Ned Tijdschr Geneeskd (2001) 1.39
[Poor results of treatment of echinococcosis with albendazole in 7 patients]. Ned Tijdschr Geneeskd (1994) 1.38
Antihypoxic treatment at an early stage of diabetic neuropathy: an electrophysiological study with sabeluzole. Acta Neurol Scand (1992) 1.38
['Neurodevelopmental treatment' following stroke: no beneficial effect shown in measurements taken after 1 year; comparative study]. Ned Tijdschr Geneeskd (2007) 1.38
[Carotid endarterectomy indicated in asymptomatic stenosis]. Ned Tijdschr Geneeskd (2004) 1.38
Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry (1992) 1.38
[The metabolic syndrome: a cluster of vascular risk factors]. Ned Tijdschr Geneeskd (2005) 1.38
[The diagnosis of pulmonary embolism: the best strategies according to the results of a large Dutch multicentre study]. Ned Tijdschr Geneeskd (2005) 1.38
Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology (1996) 1.38
The prognostic value of domain-specific cognitive abilities in acute first-ever stroke. Neurology (2005) 1.36
Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol (1999) 1.35
Risk factors for subarachnoid hemorrhage: a systematic review. Stroke (1996) 1.35
Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol (2000) 1.35
Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event. J Neurol Neurosurg Psychiatry (2007) 1.35
Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA (2001) 1.34
Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke (1999) 1.30
Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J Thromb Haemost (2005) 1.29
Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol (1992) 1.23
Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2005) 1.23
Variability of flow mediated dilation: consequences for clinical application. Atherosclerosis (2001) 1.19
Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. Stroke (1998) 1.19
Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis. Br J Surg (1997) 1.18
Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology (2000) 1.16
Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2004) 1.16
A rational approach to dose reduction in CT: individualized scan protocols. Eur Radiol (2001) 1.14
Breast arterial calcifications: association with diabetes mellitus and cardiovascular mortality. Work in progress. Radiology (1996) 1.14
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2005) 1.13
Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev (2005) 1.12
Mayo and NINDS scales for assessment of tendon reflexes: between observer agreement and implications for communication. J Neurol Neurosurg Psychiatry (1998) 1.11
Subarachnoid hemorrhage: aneurysm detection and preoperative evaluation with CT angiography. Radiology (1998) 1.11
[Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities]. Ned Tijdschr Geneeskd (2008) 1.10
Familial subarachnoid hemorrhage: distinctive features and patterns of inheritance. Ann Neurol (1995) 1.10
Cognition after carotid endarterectomy or stenting: a randomized comparison. Neurology (2011) 1.09
Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial. Lancet Neurol (2007) 1.08
Level set based cerebral vasculature segmentation and diameter quantification in CT angiography. Med Image Anal (2005) 1.08
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2003) 1.07
Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology (2002) 1.07
Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation (1992) 1.07